Learn More
Invitrogen™ Human PLD5 (aa 455-536) Control Fragment Recombinant Protein
Recombinant Protein
Supplier: Invitrogen™ RP94481
Description
Highest antigen sequence indentity to the following orthologs: Mouse (78%), Rat (78%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-55834 (PA5-55834. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The specific function of the protein remains unknown.- Environmental benefits include:
- Renewable Energy
- Recyclable
- Non-Toxic
Specifications
Q8N7P1 | |
Blocking Assay, Control | |
200150 | |
100 ÎĽL | |
Inactive choline phosphatase 5; inactive phosphatidylcholine-hydrolyzing phospholipase D5; Inactive phospholipase D5; inactive PLD 5; phospholipase D family member 5; phospholipase D family, member 5; PLD5; PLDc | |
PLD5 | |
Human | |
His-ABP-tag | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
≥5.0 mg/mL | |
1 M urea, PBS with no preservative; pH 7.4 | |
Human PLD5 (aa 455-536) Control Fragment | |
RUO | |
PLD5 | |
Unconjugated | |
Recombinant | |
DWVGNDFTQNAGTGLVINQADVRNNRSIIKQLKDVFERDWYSPYAKTLQPTKQPNCSSLFKLKPLSNKTATDDTGGKDPRNV | |
E. coli | |
>80% by SDS-PAGE and Coomassie blue staining |